Clinical research studyCardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
Keywords
Cited by (0)
Funding: The present work was supported by the Swiss National Science Foundation (TFL) and the Foundation for Cardiovascular Research – Zurich Heart House, Zurich, Switzerland. Copyright permission and publication costs were supported by Boehringer Ingelheim Pharmaceuticals, Inc. FP is the recipient of a Sheikh Khalifa’s Foundation Assistant Professorship at the Faculty of Medicine, University of Zurich. The other author received no direct compensation related to the development of the manuscript.
Conflict of Interest: The authors have no actual or potential conflict of interest, including any financial, personal, or other relationships with other people or organizations.
Authorship: The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors were fully responsible for all content and editorial decisions, were involved at all stages of manuscript development, and approved the final version that reflects the authors' interpretations and conclusions. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations.
This article is co-published in The American Journal of Medicine (Vol. 130, Issue 6S, June 2017) and The American Journal of Cardiology (Vol. 120, Issue 1S, July 1, 2017).